Table 4.
Incidence of prostate cancer upstaging regarding T stage after mpMRI
| cT1–2 Tumors | n | Tumor upstaging (n) | Percentage of tumor upstaging |
|---|---|---|---|
| Gleason score < 7 | 42 | 19 | 45.2% |
| Gleason score 7 | 40 | 24 | 60% |
| Gleason score > 7 | 15 | 8 | 53% |
| PSA level < 10 ng/ml | 44 | 22 | 50% |
| PSA level 10–20 ng/ml | 30 | 16 | 53.3% |
| PSA level > 20 ng/ml | 23 | 17 | 73.9% |
Incidence of prostate cancer upstaging regarding T stage after mpMRI depending on initial serum PSA level and the Gleason score in patients initially staged as cT1–cT2 (n = 97).